(82)Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis

BACKGROUND: Accurate identification and discrimination of post treatment changes from recurrent disease remains a challenge for patients with intracranial malignancies despite advances in molecular and magnetic resonance imaging. We have explored the ability of readily available Rubidium-82 chloride...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Q J Nucl Med Mol Imaging
Egile Nagusiak: PARENT, Ephraim E., SETHI, Ila, NYE, Jonathon, HOLDER, Chad, OLSON, Jeffrey J., SWITCHENKO, Jeffrey, TADE, Funmilayo, AKIN-AKINTAYO, Oladunni O., ABIODUN-OJO, Olayinka A., AKINTAYO, Akinyemi, SCHUSTER, David M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2022
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958885/
https://ncbi.nlm.nih.gov/pubmed/31820882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23736/S1824-4785.19.03173-X
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak